SCHEMBL10692526

SCHEMBL10692526

CC1C(=O)N(C)Oc2cc(C(=O)C3CC3)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 2/20 0.37
KDM2B Q8NHM5 1/20 0.37
SMN1; SMN2 Q16637 6/20 0.36
LMNA P02545 5/20 0.36
GAA P10253 4/20 0.36
ALDH1A1 P00352 3/20 0.36
HRH3 Q9Y5N1 2/20 0.36
HTR1F P30939 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KMT2A Q03164 3/20 0.35
TSHR P16473 2/20 0.35
CYP2D6 P10635 2/20 0.35
MEN1 O00255 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
HTT P42858 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10692456 0.75 GRM1 (0.38) MGLLSMN1; SMN2LMNAGAAALDH1A1
SCHEMBL10693172 0.75 KMT2A (0.38) MGLLSMN1; SMN2LMNAGAAALDH1A1
SCHEMBL10693327 0.73 XDH (0.49) LMNAGAAALDH1A1KMT2AMEN1
SCHEMBL28953638 0.64 ALDH1A1 (0.62) SMN1; SMN2LMNAGAAALDH1A1HSD17B10
SCHEMBL8895195 0.64 SMN1; SMN2 (0.64) MGLLKDM2BSMN1; SMN2LMNAGAA
SCHEMBL16058772 0.64 PBRM1 (0.42) LMNAALDH1A1KMT2ATSHRMEN1
SCHEMBL14067799 0.64 NPSR1 (0.49) MGLLKDM2BSMN1; SMN2GAAALDH1A1
SCHEMBL8367098 0.62 PRMT5 (0.44) KDM2BSMN1; SMN2LMNAGAAALDH1A1
SCHEMBL6183451 0.60 ALDH1A1 (0.61) MGLLSMN1; SMN2ALDH1A1KMT2ACYP2D6
SCHEMBL13268159 0.60 NPC1 (0.46) MGLLLMNAKMT2ACYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4778792-A Use of 7-acyl benzoxazinones and their derivatives in treating atheromatous disorders LABORATORIES NEGMA (FR) 1988-10-18 US disclosed